Ymhellach i WQ91377, pa gymorth a roddir i symleiddio profion mwtaniad BCRA ar gyfer pobl sy'n fwy tebygol o gael mwtaniadau ond heb ddiagnosis canser teuluol o'r radd gyntaf neu ail radd, yn enwedig wrth gyfeirio at gysylltiadau teuluol sydd wedi cael profion y tu allan i'r DU?
BRCA gene testing is not routinely offered for people with no family history of cancer, unless they are affected by cancer themselves or there is confirmed familial predisposition with a pathogenic gene alteration identified in a relative.
When people have a relative with a pathogenic gene alteration identified through testing overseas, the All Wales Medical Genomics Service (AWMGS) would obtain signed consent from the relative via the patient to contact the testing centre for further information to support the patient.
Throughout the process, people would have access to the same information and support from AWMGS as those with familial connections tested in the UK. This approach is in accordance with NICE guidance and National Genomic Test Directory.